Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 442.0 | 43 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 312.0 | 47 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 532.5 | 48 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 342.0 | 42 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 206.5 | 52 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 275.0 | 45 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 337.0 | 33 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 305.0 | 41 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 390.0 | 37 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 217.0 | 40 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 544.0 | 37 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 371.5 | 38 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 400.0 | 43 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | M-CSF | 349.5 | 44 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 549.0 | 55 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | M-CSF | 538.5 | 48 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 457.0 | 37 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | M-CSF | 533.5 | 64 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 496.5 | 44 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | M-CSF | 423.0 | 51 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 387.0 | 48 | ||||
RA1869 | 1 | M-CSF | 399.0 | 33 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 591.0 | 34 | ||||
N2759 | 1 | M-CSF | 662.0 | 44 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 443.0 | 33 |